TY - JOUR AU - Egan, B. M. AU - Zhao, Y. AU - Axon, R. N. PY - 2010 DA - 2010// TI - US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008 JO - JAMA VL - 303 UR - https://doi.org/10.1001/jama.2010.650 DO - 10.1001/jama.2010.650 ID - Egan2010 ER - TY - JOUR AU - Ezzati, M. AU - Oza, S. AU - Danaei, G. AU - Murray, C. J. PY - 2008 DA - 2008// TI - Trends and cardiovascular mortality effects of state-level blood pressure and uncontrolled hypertension in the United States JO - Circulation VL - 117 UR - https://doi.org/10.1161/CIRCULATIONAHA.107.732131 DO - 10.1161/CIRCULATIONAHA.107.732131 ID - Ezzati2008 ER - TY - JOUR AU - Ostchega, Y. AU - Dillon, C. F. AU - Hughes, J. P. AU - Carroll, M. AU - Yoon, S. PY - 2007 DA - 2007// TI - Trends in hypertension prevalence, awareness, treatment, and control in older U.S. adults: data from the National Health and Nutrition Examination Survey 1988 to 2004 JO - J Am Geriatr Soc VL - 55 UR - https://doi.org/10.1111/j.1532-5415.2007.01215.x DO - 10.1111/j.1532-5415.2007.01215.x ID - Ostchega2007 ER - TY - JOUR AU - Krause, T. AU - Lovibond, K. AU - Caulfield, M. AU - McCormack, T. AU - Williams, B. PY - 2011 DA - 2011// TI - Management of hypertension: summary of NICE guidance JO - BMJ VL - 343 UR - https://doi.org/10.1136/bmj.d4891 DO - 10.1136/bmj.d4891 ID - Krause2011 ER - TY - JOUR AU - Chobanian, A. V. AU - Bakris, G. L. AU - Black, H. R. AU - Cushman, W. C. AU - Green, L. A. AU - Izzo, J. L. AU - Jones, D. W. AU - Materson, B. J. AU - Oparil, S. AU - Wright, J. T. AU - Roccella, E. J. PY - 2003 DA - 2003// TI - Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure JO - Hypertension VL - 42 UR - https://doi.org/10.1161/01.HYP.0000107251.49515.c2 DO - 10.1161/01.HYP.0000107251.49515.c2 ID - Chobanian2003 ER - TY - JOUR AU - Mancia, G. AU - De, B. G. AU - Dominiczak, A. AU - Cifkova, R. AU - Fagard, R. AU - Germano, G. AU - Grassi, G. AU - Heagerty, A. M. AU - Kjeldsen, S. E. AU - Laurent, S. AU - Narkiewicz, K. AU - Ruilope, L. AU - Rynkiewicz, A. AU - Schmieder, R. E. AU - Boudier, H. A. AU - Zanchetti, A. AU - Vahanian, A. AU - Camm, J. AU - De, C. R. AU - Dean, V. AU - Dickstein, K. AU - Filippatos, G. AU - Funck-Brentano, C. AU - Hellemans, I. AU - Kristensen, S. D. AU - McGregor, K. AU - Sechtem, U. AU - Silber, S. AU - Tendera, M. AU - Widimsky, P. AU - Zamorano, J. L. AU - Erdine, S. AU - Kiowski, W. AU - Agabiti-Rosei, E. AU - Ambrosioni, E. AU - Lindholm, L. H. AU - Viigimaa, M. AU - Adamopoulos, S. AU - Agabiti-Rosei, E. AU - Ambrosioni, E. AU - Bertomeu, V. AU - Clement, D. AU - Erdine, S. AU - Farsang, C. AU - Gaita, D. AU - Lip, G. AU - Mallion, J. M. AU - Manolis, A. J. AU - Nilsson, P. M. AU - O'Brien, E. AU - Ponikowski, P. AU - Redon, J. AU - Ruschitzka, F. AU - Tamargo, J. AU - Van, Z. P. AU - Waeber, B. AU - Williams, B. PY - 2007 DA - 2007// TI - 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) JO - J Hypertens VL - 25 UR - https://doi.org/10.1097/HJH.0b013e3281fc975a DO - 10.1097/HJH.0b013e3281fc975a ID - Mancia2007 ER - TY - JOUR AU - Mancia, G. AU - Laurent, S. AU - Agabiti-Rosei, E. AU - Ambrosioni, E. AU - Burnier, M. AU - Caulfield, M. J. AU - Cifkova, R. AU - Clement, D. AU - Coca, A. AU - Dominiczak, A. AU - Erdine, S. AU - Fagard, R. AU - Farsang, C. AU - Grassi, G. AU - Haller, H. AU - Heagerty, A. AU - Kjeldsen, S. E. AU - Kiowski, W. AU - Mallion, J. M. AU - Manolis, A. AU - Narkiewicz, K. AU - Nilsson, P. AU - Olsen, M. H. AU - Rahn, K. H. AU - Redon, J. AU - Rodicio, J. AU - Ruilope, L. AU - Schmieder, R. E. AU - Struijker-Boudier, H. A. AU - van Zwieten, P. A. AU - Viigimaa, M. AU - Zanchetti, A. PY - 2009 DA - 2009// TI - Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document JO - J Hypertens VL - 27 UR - https://doi.org/10.1097/HJH.0b013e328333146d DO - 10.1097/HJH.0b013e328333146d ID - Mancia2009 ER - TY - JOUR AU - Ogihara, T. AU - Kikuchi, K. AU - Matsuoka, H. AU - Fujita, T. AU - Higaki, J. AU - Horiuchi, M. AU - Imai, Y. AU - Imaizumi, T. AU - Ito, S. AU - Iwao, H. AU - Kario, K. AU - Kawano, Y. AU - Kim-Mitsuyama, S. AU - Kimura, G. AU - Matsubara, H. AU - Matsuura, H. AU - Naruse, M. AU - Saito, I. AU - Shimada, K. AU - Shimamoto, K. AU - Suzuki, H. AU - Takishita, S. AU - Tanahashi, N. AU - Tsuchihashi, T. AU - Uchiyama, M. AU - Ueda, S. AU - Ueshima, H. AU - Umemura, S. AU - Ishimitsu, T. AU - Rakugi, H. PY - 2009 DA - 2009// TI - The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009) JO - Hypertens Res VL - 32 ID - Ogihara2009 ER - TY - JOUR AU - Dickson, M. AU - Plauschinat, C. A. PY - 2008 DA - 2008// TI - Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy JO - Am J Cardiovasc Drugs VL - 8 UR - https://doi.org/10.2165/00129784-200808010-00006 DO - 10.2165/00129784-200808010-00006 ID - Dickson2008 ER - TY - JOUR AU - Frank, J. PY - 2008 DA - 2008// TI - Managing hypertension using combination therapy JO - Am Fam Physician VL - 77 ID - Frank2008 ER - TY - JOUR AU - Bangalore, S. AU - Kamalakkannan, G. AU - Parkar, S. AU - Messerli, F. H. PY - 2007 DA - 2007// TI - Fixed-dose combinations improve medication compliance: a meta-analysis JO - Am J Med VL - 120 UR - https://doi.org/10.1016/j.amjmed.2006.08.033 DO - 10.1016/j.amjmed.2006.08.033 ID - Bangalore2007 ER - TY - JOUR AU - Gupta, A. K. AU - Arshad, S. AU - Poulter, N. R. PY - 2010 DA - 2010// TI - Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis JO - Hypertension VL - 55 UR - https://doi.org/10.1161/HYPERTENSIONAHA.109.139816 DO - 10.1161/HYPERTENSIONAHA.109.139816 ID - Gupta2010 ER - TY - JOUR AU - Zeng, F. AU - Patel, B. V. AU - Andrews, L. AU - Frech-Tamas, F. AU - Rudolph, A. E. PY - 2010 DA - 2010// TI - Adherence and persistence of single-pill ARB/CCB combination therapy compared to multiple-pill ARB/CCB regimens JO - Curr Med Res Opin VL - 26 UR - https://doi.org/10.1185/03007995.2010.534129 DO - 10.1185/03007995.2010.534129 ID - Zeng2010 ER - TY - STD TI - NICE Guidelines: Management of hypertension in adults in primary care. 2011. 2011 ID - ref14 ER - TY - JOUR AU - Lewington, S. AU - Clarke, R. AU - Qizilbash, N. AU - Peto, R. AU - Collins, R. PY - 2002 DA - 2002// TI - Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies JO - Lancet VL - 360 UR - https://doi.org/10.1016/S0140-6736(02)11911-8 DO - 10.1016/S0140-6736(02)11911-8 ID - Lewington2002 ER - TY - JOUR AU - Law, M. R. AU - Wald, N. J. AU - Morris, J. K. AU - Jordan, R. E. PY - 2003 DA - 2003// TI - Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials JO - BMJ VL - 326 UR - https://doi.org/10.1136/bmj.326.7404.1427 DO - 10.1136/bmj.326.7404.1427 ID - Law2003 ER - TY - JOUR AU - Neutel, J. M. PY - 2008 DA - 2008// TI - Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients JO - Curr Med Res Opin VL - 24 UR - https://doi.org/10.1185/03007990802262457 DO - 10.1185/03007990802262457 ID - Neutel2008 ER - TY - JOUR AU - Chrysant, S. G. AU - Murray, A. V. AU - Hoppe, U. C. AU - Dattani, D. AU - Patel, S. AU - Hsu, H. AU - Zhang, J. PY - 2008 DA - 2008// TI - Long-term safety, tolerability and efficacy of aliskiren in combination with valsartan in patients with hypertension: a 6-month interim analysis JO - Curr Med Res Opin VL - 24 UR - https://doi.org/10.1185/030079908X280581 DO - 10.1185/030079908X280581 ID - Chrysant2008 ER - TY - JOUR AU - Khosla, N. AU - Kalaitzidis, R. AU - Bakris, G. L. PY - 2009 DA - 2009// TI - Predictors of hyperkalemia risk following hypertension control with aldosterone blockade JO - Am J Nephrol VL - 30 UR - https://doi.org/10.1159/000237742 DO - 10.1159/000237742 ID - Khosla2009 ER - TY - JOUR AU - Wald, D. S. AU - Law, M. AU - Morris, J. K. AU - Bestwick, J. P. AU - Wald, N. J. PY - 2009 DA - 2009// TI - Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials JO - Am J Med VL - 122 UR - https://doi.org/10.1016/j.amjmed.2008.09.038 DO - 10.1016/j.amjmed.2008.09.038 ID - Wald2009 ER - TY - JOUR AU - Pimenta, E. AU - Oparil, S. PY - 2008 DA - 2008// TI - Fixed combinations in the management of hypertension: patient perspectives and rationale for development and utility of the olmesartan-amlodipine combination JO - Vasc Health Risk Manag VL - 4 ID - Pimenta2008 ER - TY - JOUR AU - Bohm, M. AU - Thoenes, M. AU - Danchin, N. AU - Bramlage, P. AU - La, P. P. AU - Volpe, M. PY - 2007 DA - 2007// TI - Association of cardiovascular risk factors with microalbuminuria in hypertensive individuals: the i-SEARCH global study JO - J Hypertens VL - 25 UR - https://doi.org/10.1097/HJH.0b013e3282ef1c5f DO - 10.1097/HJH.0b013e3282ef1c5f ID - Bohm2007 ER - TY - JOUR AU - Gradman, A. H. AU - Basile, J. N. AU - Carter, B. L. AU - Bakris, G. L. PY - 2011 DA - 2011// TI - Combination therapy in hypertension JO - J Clin Hypertens (Greenwich ) VL - 13 UR - https://doi.org/10.1111/j.1751-7176.2010.00397.x DO - 10.1111/j.1751-7176.2010.00397.x ID - Gradman2011 ER - TY - JOUR AU - Flack, J. M. AU - Sica, D. A. AU - Bakris, G. AU - Brown, A. L. AU - Ferdinand, K. C. AU - Grimm, R. H. AU - Hall, W. D. AU - Jones, W. E. AU - Kountz, D. S. AU - Lea, J. P. AU - Nasser, S. AU - Nesbitt, S. D. AU - Saunders, E. AU - Scisney-Matlock, M. AU - Jamerson, K. A. PY - 2010 DA - 2010// TI - Management of high blood pressure in Blacks: an update of the International Society on Hypertension in Blacks consensus statement JO - Hypertension VL - 56 UR - https://doi.org/10.1161/HYPERTENSIONAHA.110.152892 DO - 10.1161/HYPERTENSIONAHA.110.152892 ID - Flack2010 ER - TY - JOUR AU - Mogensen, C. E. AU - Neldam, S. AU - Tikkanen, I. AU - Oren, S. AU - Viskoper, R. AU - Watts, R. W. AU - Cooper, M. E. PY - 2000 DA - 2000// TI - Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study JO - BMJ VL - 321 UR - https://doi.org/10.1136/bmj.321.7274.1440 DO - 10.1136/bmj.321.7274.1440 ID - Mogensen2000 ER - TY - JOUR AU - Mann, J. F. AU - Schmieder, R. E. AU - McQueen, M. AU - Dyal, L. AU - Schumacher, H. AU - Pogue, J. AU - Wang, X. AU - Maggioni, A. AU - Budaj, A. AU - Chaithiraphan, S. AU - Dickstein, K. AU - Keltai, M. AU - Metsarinne, K. AU - Oto, A. AU - Parkhomenko, A. AU - Piegas, L. S. AU - Svendsen, T. L. AU - Teo, K. K. AU - Yusuf, S. PY - 2008 DA - 2008// TI - Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial JO - Lancet VL - 372 UR - https://doi.org/10.1016/S0140-6736(08)61236-2 DO - 10.1016/S0140-6736(08)61236-2 ID - Mann2008 ER - TY - JOUR AU - Pfeffer, M. A. AU - McMurray, J. J. AU - Velazquez, E. J. AU - Rouleau, J. L. AU - Kober, L. AU - Maggioni, A. P. AU - Solomon, S. D. AU - Swedberg, K. AU - Van de Werf, F. AU - White, H. AU - Leimberger, J. D. AU - Henis, M. AU - Edwards, S. AU - Zelenkofske, S. AU - Sellers, M. A. AU - Califf, R. M. PY - 2003 DA - 2003// TI - Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both JO - N Engl J Med VL - 349 UR - https://doi.org/10.1056/NEJMoa032292 DO - 10.1056/NEJMoa032292 ID - Pfeffer2003 ER - TY - JOUR AU - Solomon, S. D. AU - Appelbaum, E. AU - Manning, W. J. AU - Verma, A. AU - Berglund, T. AU - Lukashevich, V. AU - Cherif, P. C. AU - Smith, B. A. AU - Dahlof, B. PY - 2009 DA - 2009// TI - Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy JO - Circulation VL - 119 UR - https://doi.org/10.1161/CIRCULATIONAHA.108.826214 DO - 10.1161/CIRCULATIONAHA.108.826214 ID - Solomon2009 ER - TY - JOUR AU - Tobe, S. W. AU - Clase, C. M. AU - Gao, P. AU - McQueen, M. AU - Grosshennig, A. AU - Wang, X. AU - Teo, K. K. AU - Yusuf, S. AU - Mann, J. F. PY - 2011 DA - 2011// TI - Cardiovascular and renal outcomes with telmisartan, ramipril, or both in people at high renal risk: results from the ONTARGET and TRANSCEND studies JO - Circulation VL - 123 UR - https://doi.org/10.1161/CIRCULATIONAHA.110.964171 DO - 10.1161/CIRCULATIONAHA.110.964171 ID - Tobe2011 ER - TY - JOUR AU - Bangalore, S. AU - Kumar, S. AU - Messerli, F. H. PY - 2010 DA - 2010// TI - Angiotensin-converting enzyme inhibitor associated cough: deceptive information from the Physicians' Desk Reference JO - Am J Med VL - 123 UR - https://doi.org/10.1016/j.amjmed.2010.06.014 DO - 10.1016/j.amjmed.2010.06.014 ID - Bangalore2010 ER - TY - JOUR AU - Weber, M. A. AU - Messerli, F. H. PY - 2008 DA - 2008// TI - Angiotensin-converting enzyme inhibitors and angioedema: estimating the risk JO - Hypertension VL - 51 UR - https://doi.org/10.1161/HYPERTENSIONAHA.108.111393 DO - 10.1161/HYPERTENSIONAHA.108.111393 ID - Weber2008 ER - TY - JOUR AU - Yusuf, S. AU - Teo, K. K. AU - Pogue, J. AU - Dyal, L. AU - Copland, I. AU - Schumacher, H. AU - Dagenais, G. AU - Sleight, P. AU - Anderson, C. PY - 2008 DA - 2008// TI - Telmisartan, ramipril, or both in patients at high risk for vascular events JO - N Engl J Med VL - 358 UR - https://doi.org/10.1056/NEJMoa0801317 DO - 10.1056/NEJMoa0801317 ID - Yusuf2008 ER - TY - JOUR AU - Lacourciere, Y. PY - 2000 DA - 2000// TI - A multicenter, randomized, double-blind study of the antihypertensive efficacy and tolerability of irbesartan in patients aged > or = 65 years with mild to moderate hypertension JO - Clin Ther VL - 22 UR - https://doi.org/10.1016/S0149-2918(00)83064-7 DO - 10.1016/S0149-2918(00)83064-7 ID - Lacourciere2000 ER - TY - JOUR AU - Yusuf, S. AU - Teo, K. AU - Anderson, C. AU - Pogue, J. AU - Dyal, L. AU - Copland, I. AU - Schumacher, H. AU - Dagenais, G. AU - Sleight, P. PY - 2008 DA - 2008// TI - Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial JO - Lancet VL - 372 UR - https://doi.org/10.1016/S0140-6736(08)61242-8 DO - 10.1016/S0140-6736(08)61242-8 ID - Yusuf2008 ER - TY - JOUR AU - Corrao, G. AU - Zambon, A. AU - Parodi, A. AU - Poluzzi, E. AU - Baldi, I. AU - Merlino, L. AU - Cesana, G. AU - Mancia, G. PY - 2008 DA - 2008// TI - Discontinuation of and changes in drug therapy for hypertension among newly-treated patients: a population-based study in Italy JO - J Hypertens VL - 26 UR - https://doi.org/10.1097/HJH.0b013e3282f4edd7 DO - 10.1097/HJH.0b013e3282f4edd7 ID - Corrao2008 ER - TY - JOUR AU - Kjeldsen, S. E. AU - Os, I. AU - Hoieggen, A. AU - Beckey, K. AU - Gleim, G. W. AU - Oparil, S. PY - 2005 DA - 2005// TI - Fixed-dose combinations in the management of hypertension: defining the place of angiotensin receptor antagonists and hydrochlorothiazide JO - Am J Cardiovasc Drugs VL - 5 UR - https://doi.org/10.2165/00129784-200505010-00003 DO - 10.2165/00129784-200505010-00003 ID - Kjeldsen2005 ER - TY - JOUR AU - Littlejohn, T. W. AU - Majul, C. R. AU - Olvera, R. AU - Seeber, M. AU - Kobe, M. AU - Guthrie, R. AU - Oigman, W. PY - 2009 DA - 2009// TI - Telmisartan plus amlodipine in patients with moderate or severe hypertension: results from a subgroup analysis of a randomized, placebo-controlled, parallel-group, 4 × 4 factorial study JO - Postgrad Med VL - 121 UR - https://doi.org/10.3810/pgm.2009.03.1972 DO - 10.3810/pgm.2009.03.1972 ID - Littlejohn2009 ER - TY - JOUR AU - Makani, H. AU - Bangalore, S. AU - Romero, J. AU - Wever-Pinzon, O. AU - Messerli, F. H. PY - 2011 DA - 2011// TI - Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema JO - Am J Med VL - 124 UR - https://doi.org/10.1016/j.amjmed.2010.08.007 DO - 10.1016/j.amjmed.2010.08.007 ID - Makani2011 ER - TY - JOUR AU - Oparil, S. AU - Weber, M. PY - 2009 DA - 2009// TI - Angiotensin receptor blocker and dihydropyridine calcium channel blocker combinations: an emerging strategy in hypertension therapy JO - Postgrad Med VL - 121 UR - https://doi.org/10.3810/pgm.2009.03.1974 DO - 10.3810/pgm.2009.03.1974 ID - Oparil2009 ER - TY - JOUR AU - Philipp, T. AU - Smith, T. R. AU - Glazer, R. AU - Wernsing, M. AU - Yen, J. AU - Jin, J. AU - Schneider, H. AU - Pospiech, R. PY - 2007 DA - 2007// TI - Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension JO - Clin Ther VL - 29 UR - https://doi.org/10.1016/j.clinthera.2007.03.018 DO - 10.1016/j.clinthera.2007.03.018 ID - Philipp2007 ER - TY - JOUR AU - Fletcher, A. AU - Bulpitt, C. PY - 1992 DA - 1992// TI - Quality of life in the treatment of hypertension. The effect of calcium antagonists JO - Drugs VL - 44 UR - https://doi.org/10.2165/00003495-199200441-00026 DO - 10.2165/00003495-199200441-00026 ID - Fletcher1992 ER - TY - JOUR AU - Pedrinelli, R. AU - Dell'Omo, G. AU - Mariani, M. PY - 2001 DA - 2001// TI - Calcium channel blockers, postural vasoconstriction and dependent oedema in essential hypertension JO - J Hum Hypertens VL - 15 UR - https://doi.org/10.1038/sj.jhh.1001201 DO - 10.1038/sj.jhh.1001201 ID - Pedrinelli2001 ER - TY - JOUR AU - de la Sierra, A. PY - 2009 DA - 2009// TI - Mitigation of calcium channel blocker-related oedema in hypertension by antagonists of the renin-angiotensin system JO - J Hum Hypertens VL - 23 UR - https://doi.org/10.1038/jhh.2008.157 DO - 10.1038/jhh.2008.157 ID - de la Sierra2009 ER - TY - JOUR AU - Makani, H. AU - Bangalore, S. AU - Romero, J. AU - Wever-Pinzon, O. AU - Messerli, F. H. PY - 2011 DA - 2011// TI - Effect of renin-angiotensin system blockade on calcium channel blocker-associated peripheral edema JO - Am J Med VL - 124 UR - https://doi.org/10.1016/j.amjmed.2010.08.007 DO - 10.1016/j.amjmed.2010.08.007 ID - Makani2011 ER - TY - JOUR AU - Fogari, R. AU - Mugellini, A. AU - Zoppi, A. AU - Lazzari, P. AU - Destro, M. AU - Rinaldi, A. AU - Preti, P. PY - 2006 DA - 2006// TI - Effect of telmisartan/hydrochlorothiazide vs lisinopril/hydrochlorothiazide combination on ambulatory blood pressure and cognitive function in elderly hypertensive patients JO - J Hum Hypertens VL - 20 UR - https://doi.org/10.1038/sj.jhh.1001964 DO - 10.1038/sj.jhh.1001964 ID - Fogari2006 ER - TY - JOUR AU - Gosse, P. AU - Neutel, J. M. AU - Schumacher, H. AU - Lacourciere, Y. AU - Williams, B. AU - Davidai, G. PY - 2007 DA - 2007// TI - The effect of telmisartan and ramipril on early morning blood pressure surge: a pooled analysis of two randomized clinical trials JO - Blood Press Monit VL - 12 UR - https://doi.org/10.1097/MBP.0b013e3280b10bbd DO - 10.1097/MBP.0b013e3280b10bbd ID - Gosse2007 ER - TY - JOUR AU - Lacourciere, Y. AU - Neutel, J. M. AU - Davidai, G. AU - Koval, S. PY - 2006 DA - 2006// TI - A multicenter, 14-week study of telmisartan and ramipril in patients with mild-to-moderate hypertension using ambulatory blood pressure monitoring JO - Am J Hypertens VL - 19 UR - https://doi.org/10.1016/j.amjhyper.2005.10.001 DO - 10.1016/j.amjhyper.2005.10.001 ID - Lacourciere2006 ER - TY - JOUR AU - Nalbantgil, I. AU - Nalbantgil, S. AU - Ozerkan, F. AU - Yilmaz, H. AU - Gurgun, C. AU - Zoghi, M. AU - Aytimur, M. AU - Onder, R. PY - 2004 DA - 2004// TI - The efficacy of telmisartan compared with perindopril in patients with mild-to-moderate hypertension JO - Int J Clin Pract Suppl VL - 145 UR - https://doi.org/10.1111/j.1742-1241.2004.00411.x DO - 10.1111/j.1742-1241.2004.00411.x ID - Nalbantgil2004 ER - TY - JOUR AU - Ragot, S. AU - Ezzaher, A. AU - Meunier, A. AU - Poterre, M. AU - Bourkaib, R. AU - Herpin, D. PY - 2002 DA - 2002// TI - Comparison of trough effect of telmisartan vs perindopril using self blood pressure measurement: EVERESTE study JO - J Hum Hypertens VL - 16 UR - https://doi.org/10.1038/sj.jhh.1001494 DO - 10.1038/sj.jhh.1001494 ID - Ragot2002 ER - TY - JOUR AU - Williams, B. AU - Gosse, P. AU - Lowe, L. AU - Harper, R. PY - 2006 DA - 2006// TI - The prospective, randomized investigation of the safety and efficacy of telmisartan versus ramipril using ambulatory blood pressure monitoring (PRISMA I) JO - J Hypertens VL - 24 UR - https://doi.org/10.1097/01.hjh.0000194364.11516.ab DO - 10.1097/01.hjh.0000194364.11516.ab ID - Williams2006 ER - TY - JOUR AU - Nishida, Y. AU - Takahashi, Y. AU - Nakayama, T. AU - Soma, M. AU - Asai, S. PY - 2011 DA - 2011// TI - Comparative effect of olmesartan and candesartan on lipid metabolism and renal function in patients with hypertension: a retrospective observational study JO - Cardiovasc Diabetol VL - 10 UR - https://doi.org/10.1186/1475-2840-10-74 DO - 10.1186/1475-2840-10-74 ID - Nishida2011 ER - TY - JOUR AU - Nishida, Y. AU - Takahashi, Y. AU - Nakayama, T. AU - Soma, M. AU - Kitamura, N. AU - Asai, S. PY - 2010 DA - 2010// TI - Effect of candesartan monotherapy on lipid metabolism in patients with hypertension: a retrospective longitudinal survey using data from electronic medical records JO - Cardiovasc Diabetol VL - 9 UR - https://doi.org/10.1186/1475-2840-9-38 DO - 10.1186/1475-2840-9-38 ID - Nishida2010 ER - TY - JOUR AU - Sipahi, I. AU - Debanne, S. M. AU - Rowland, D. Y. AU - Simon, D. I. AU - Fang, J. C. PY - 2010 DA - 2010// TI - Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials JO - Lancet Oncol VL - 11 UR - https://doi.org/10.1016/S1470-2045(10)70106-6 DO - 10.1016/S1470-2045(10)70106-6 ID - Sipahi2010 ER - TY - STD TI - Effects of telmisartan, irbesartan, valsartan, candesartan, and losartan on cancers in 15 trials enrolling 138,769 individuals. J Hypertens. 2011, 29 (4): 623-635. ID - ref54 ER - TY - JOUR AU - Bangalore, S. AU - Kumar, S. AU - Kjeldsen, S. E. AU - Makani, H. AU - Grossman, E. AU - Wetterslev, J. AU - Gupta, A. K. AU - Sever, P. S. AU - Gluud, C. AU - Messerli, F. H. PY - 2011 DA - 2011// TI - Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials JO - Lancet Oncol VL - 12 UR - https://doi.org/10.1016/S1470-2045(10)70260-6 DO - 10.1016/S1470-2045(10)70260-6 ID - Bangalore2011 ER - TY - JOUR AU - Izzo, J. L. AU - Zion, A. S. PY - 2011 DA - 2011// TI - Value of Angiotensin receptor blocker therapy in diabetes JO - J Clin Hypertens (Greenwich ) VL - 13 UR - https://doi.org/10.1111/j.1751-7176.2011.00447.x DO - 10.1111/j.1751-7176.2011.00447.x ID - Izzo2011 ER - TY - JOUR PY - 2008 DA - 2008// TI - Standards of medical care in diabetes JO - Diabetes Care VL - 31 UR - https://doi.org/10.2337/dc08-S012 DO - 10.2337/dc08-S012 ID - ref57 ER - TY - JOUR AU - Trimarchi, H. PY - 2011 DA - 2011// TI - Role of aliskiren in blood pressure control and renoprotection JO - Int J Nephrol Renovasc Dis VL - 4 UR - https://doi.org/10.2147/IJNRD.S6653 DO - 10.2147/IJNRD.S6653 ID - Trimarchi2011 ER - TY - JOUR AU - Parving, H. H. AU - Brenner, B. M. AU - McMurray, J. J. AU - de, Z. D. AU - Haffner, S. M. AU - Solomon, S. D. AU - Chaturvedi, N. AU - Ghadanfar, M. AU - Weissbach, N. AU - Xiang, Z. AU - Armbrecht, J. AU - Pfeffer, M. A. PY - 2009 DA - 2009// TI - Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design JO - Nephrol Dial Transplant VL - 24 UR - https://doi.org/10.1093/ndt/gfn721 DO - 10.1093/ndt/gfn721 ID - Parving2009 ER - TY - JOUR AU - Chrysant, S. G. AU - Chrysant, G. S. PY - 2004 DA - 2004// TI - Antihypertensive efficacy of olmesartan medoxomil alone and in combination with hydrochlorothiazide JO - Expert Opin Pharmacother VL - 5 UR - https://doi.org/10.1517/14656566.5.3.657 DO - 10.1517/14656566.5.3.657 ID - Chrysant2004 ER - TY - JOUR AU - Flack, J. M. PY - 2007 DA - 2007// TI - Maximising antihypertensive effects of angiotensin II receptor blockers with thiazide diuretic combination therapy: focus on irbesartan/hydrochlorothiazide JO - Int J Clin Pract VL - 61 UR - https://doi.org/10.1111/j.1742-1241.2007.01577.x DO - 10.1111/j.1742-1241.2007.01577.x ID - Flack2007 ER - TY - JOUR AU - Lacourciere, Y. AU - Poirier, L. AU - Hebert, D. AU - Assouline, L. AU - Stolt, P. AU - Rehel, B. AU - Khder, Y. PY - 2005 DA - 2005// TI - Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial JO - Clin Ther VL - 27 UR - https://doi.org/10.1016/j.clinthera.2005.07.010 DO - 10.1016/j.clinthera.2005.07.010 ID - Lacourciere2005 ER - TY - JOUR AU - Ram, C. V. PY - 2004 DA - 2004// TI - Antihypertensive efficacy of angiotensin receptor blockers in combination with hydrochlorothiazide: a review of the factorial-design studies JO - J Clin Hypertens (Greenwich ) VL - 6 UR - https://doi.org/10.1111/j.1524-6175.2004.02632.x DO - 10.1111/j.1524-6175.2004.02632.x ID - Ram2004 ER - TY - JOUR AU - Brachmann, J. AU - Ansari, A. AU - Mahla, G. AU - Handrock, R. AU - Klebs, S. PY - 2008 DA - 2008// TI - Effective and safe reduction of blood pressure with the combination of amlodipine 5 mg and valsartan 160 mg in hypertensive patients not controlled by calcium channel blocker monotherapy JO - Adv Ther VL - 25 UR - https://doi.org/10.1007/s12325-008-0054-6 DO - 10.1007/s12325-008-0054-6 ID - Brachmann2008 ER - TY - JOUR AU - Chrysant, S. G. AU - Melino, M. AU - Karki, S. AU - Lee, J. AU - Heyrman, R. PY - 2010 DA - 2010// TI - The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study JO - Clin Ther VL - 24 ID - Chrysant2010 ER - TY - JOUR AU - Chrysant, S. G. AU - Lee, J. AU - Melino, M. AU - Karki, S. AU - Heyrman, R. PY - 2010 DA - 2010// TI - Efficacy and tolerability of amlodipine plus olmesartan medoxomil in patients with difficult-to-treat hypertension JO - J Hum Hypertens VL - 24 UR - https://doi.org/10.1038/jhh.2010.5 DO - 10.1038/jhh.2010.5 ID - Chrysant2010 ER - TY - JOUR AU - Hasebe, N. AU - Kikuchi, K. PY - 2005 DA - 2005// TI - Controlled-release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension: the NICE Combi (Nifedipine and Candesartan Combination) Study JO - J Hypertens VL - 23 UR - https://doi.org/10.1097/00004872-200502000-00028 DO - 10.1097/00004872-200502000-00028 ID - Hasebe2005 ER - TY - JOUR AU - Smith, T. R. AU - Philipp, T. AU - Vaisse, B. AU - Bakris, G. L. AU - Wernsing, M. AU - Yen, J. AU - Glazer, R. PY - 2007 DA - 2007// TI - Amlodipine and valsartan combined and as monotherapy in stage 2, elderly, and black hypertensive patients: subgroup analyses of 2 randomized, placebo-controlled studies JO - J Clin Hypertens (Greenwich ) VL - 9 UR - https://doi.org/10.1111/j.1524-6175.2007.06689.x DO - 10.1111/j.1524-6175.2007.06689.x ID - Smith2007 ER - TY - CHAP PY - 2011 DA - 2011// BT - List of authorised medicines for hypertension ID - ref69 ER - TY - JOUR AU - Burnier, M. PY - 2009 DA - 2009// TI - Telmisartan: a different angiotensin II receptor blocker protecting a different population? JO - J Int Med Res VL - 37 UR - https://doi.org/10.1177/147323000903700602 DO - 10.1177/147323000903700602 ID - Burnier2009 ER - TY - JOUR AU - Song, J. C. AU - White, C. M. PY - 2001 DA - 2001// TI - Olmesartan medoxomil (CS-866). An angiotensin II receptor blocker for treatment of hypertension JO - Formulary VL - 35 ID - Song2001 ER - TY - JOUR AU - Kakuta, H. AU - Sudoh, K. AU - Sasamata, M. AU - Yamagishi, S. PY - 2005 DA - 2005// TI - Telmisartan has the strongest binding affinity to angiotensin II type 1 receptor: comparison with other angiotensin II type 1 receptor blockers JO - Int J Clin Pharmacol Res VL - 25 ID - Kakuta2005 ER - TY - JOUR AU - Wienen, W. AU - Entzeroth, M. AU - an Meel, J. C. A. PY - 2000 DA - 2000// TI - A review on telmisartan: a novel, long-acting angiotensin II-receptor antagonist JO - Cardiovasc Drug Rev VL - 18 UR - https://doi.org/10.1111/j.1527-3466.2000.tb00039.x DO - 10.1111/j.1527-3466.2000.tb00039.x ID - Wienen2000 ER - TY - JOUR AU - Jugdutt, B. I. PY - 2010 DA - 2010// TI - Clinical effectiveness of telmisartan alone or in combination therapy for controlling blood pressure and vascular risk in the elderly JO - Clin Interv Aging VL - 5 UR - https://doi.org/10.2147/CIA.S6709 DO - 10.2147/CIA.S6709 ID - Jugdutt2010 ER - TY - JOUR AU - Tuck, M. L. PY - 2005 DA - 2005// TI - Angiotensin-receptor blocking agents and the peroxisome proliferator-activated receptor-gamma system JO - Curr Hypertens Rep VL - 7 UR - https://doi.org/10.1007/s11906-005-0019-y DO - 10.1007/s11906-005-0019-y ID - Tuck2005 ER - TY - JOUR AU - Galzerano, D. AU - Capogrosso, C. AU - Di, M. S. AU - Galzerano, A. AU - Paparello, P. AU - Lama, D. AU - Gaudio, C. PY - 2010 DA - 2010// TI - New standards in hypertension and cardiovascular risk management: focus on telmisartan JO - Vasc Health Risk Manag VL - 6 UR - https://doi.org/10.2147/VHRM.S7857 DO - 10.2147/VHRM.S7857 ID - Galzerano2010 ER - TY - JOUR AU - Unger, T. AU - Paulis, L. AU - Sica, D. A. PY - 2011 DA - 2011// TI - Therapeutic perspectives in hypertension: novel means for renin-angiotensin-aldosterone system modulation and emerging device-based approaches JO - Eur Heart J VL - 32 UR - https://doi.org/10.1093/eurheartj/ehr253 DO - 10.1093/eurheartj/ehr253 ID - Unger2011 ER - TY - CHAP AU - Cao, Z. AU - Cooper, M. E. PY - 2011 DA - 2011// TI - Efficacy of renin-angiotensin system (RAS) blockers on cardiovascular and renal outcomes in patients with type 2 diabetes BT - Acta Diabetol ID - Cao2011 ER - TY - STD TI - Azilsartan Medoxomil Prescribing Information. 2012 ID - ref79 ER - TY - JOUR AU - Ding, P. Y. AU - Chu, K. M. AU - Chiang, H. T. AU - Shu, K. H. PY - 2004 DA - 2004// TI - A double-blind ambulatory blood pressure monitoring study of the efficacy and tolerability of once-daily telmisartan 40 mg in comparison with losartan 50 mg in the treatment of mild-to-moderate hypertension in Taiwanese patients JO - Int J Clin Pract Suppl VL - 145 UR - https://doi.org/10.1111/j.1742-1241.2004.00405.x DO - 10.1111/j.1742-1241.2004.00405.x ID - Ding2004 ER - TY - JOUR AU - Lacourciere, Y. AU - Krzesinski, J. M. AU - White, W. B. AU - Davidai, G. AU - Schumacher, H. PY - 2004 DA - 2004// TI - Sustained antihypertensive activity of telmisartan compared with valsartan JO - Blood Press Monit VL - 9 UR - https://doi.org/10.1097/00126097-200408000-00005 DO - 10.1097/00126097-200408000-00005 ID - Lacourciere2004 ER - TY - JOUR AU - Mallion, J. M. AU - Baguet, J. P. AU - Siche, J. P. AU - Tremel, F. AU - De, G. R. PY - 1999 DA - 1999// TI - Cardiac and vascular remodelling: effect of antihypertensive agents JO - J Hum Hypertens VL - 13 UR - https://doi.org/10.1038/sj.jhh.1000755 DO - 10.1038/sj.jhh.1000755 ID - Mallion1999 ER - TY - JOUR AU - Nishimura, T. AU - Hashimoto, J. AU - Ohkubo, T. AU - Kikuya, M. AU - Metoki, H. AU - Asayama, K. AU - Totsune, K. AU - Imai, Y. PY - 2005 DA - 2005// TI - Efficacy and duration of action of the four selective angiotensin II subtype 1 receptor blockers, losartan, candesartan, valsartan and telmisartan, in patients with essential hypertension determined by home blood pressure measurements JO - Clin Exp Hypertens VL - 27 UR - https://doi.org/10.1081/CEH-200067668 DO - 10.1081/CEH-200067668 ID - Nishimura2005 ER - TY - JOUR AU - Sasaki, T. AU - Noda, Y. AU - Yasuoka, Y. AU - Irino, H. AU - Abe, H. AU - Adachi, H. AU - Hattori, S. AU - Kitada, H. AU - Morisawa, D. AU - Miyatake, K. PY - 2008 DA - 2008// TI - Comparison of the effects of telmisartan and olmesartan on home blood pressure, glucose, and lipid profiles in patients with hypertension, chronic heart failure, and metabolic syndrome JO - Hypertens Res VL - 31 UR - https://doi.org/10.1291/hypres.31.921 DO - 10.1291/hypres.31.921 ID - Sasaki2008 ER - TY - JOUR AU - Smith, D. H. AU - Cramer, M. J. AU - Neutel, J. M. AU - Hettiarachchi, R. AU - Koval, S. PY - 2003 DA - 2003// TI - Comparison of telmisartan versus losartan: meta-analysis of titration-to-response studies JO - Blood Press Monit VL - 8 UR - https://doi.org/10.1097/00126097-200306000-00004 DO - 10.1097/00126097-200306000-00004 ID - Smith2003 ER - TY - JOUR AU - White, W. B. AU - Lacourciere, Y. AU - Davidai, G. PY - 2004 DA - 2004// TI - Effects of the angiotensin II receptor blockers telmisartan versus valsartan on the circadian variation of blood pressure: impact on the early morning period JO - Am J Hypertens VL - 17 UR - https://doi.org/10.1016/j.amjhyper.2004.02.016 DO - 10.1016/j.amjhyper.2004.02.016 ID - White2004 ER - TY - JOUR AU - Parati, G. AU - Schumacher, H. AU - Bilo, G. AU - Mancia, G. PY - 2010 DA - 2010// TI - Evaluating 24-h antihypertensive efficacy by the smoothness index: a meta-analysis of an ambulatory blood pressure monitoring database JO - J Hypertens VL - 28 UR - https://doi.org/10.1097/HJH.0b013e32833e1150 DO - 10.1097/HJH.0b013e32833e1150 ID - Parati2010 ER - TY - JOUR AU - Littlejohn, T. AU - Mroczek, W. AU - Marbury, T. AU - VanderMaelen, C. P. AU - Dubiel, R. F. PY - 2000 DA - 2000// TI - A prospective, randomized, open-label trial comparing telmisartan 80 mg with valsartan 80 mg in patients with mild to moderate hypertension using ambulatory blood pressure monitoring JO - Can J Cardiol VL - 16 ID - Littlejohn2000 ER - TY - JOUR AU - Sharma, A. M. AU - Hollander, A. AU - Koster, J. PY - 2005 DA - 2005// TI - Telmisartan in patients with mild/moderate hypertension and chronic kidney disease JO - Clin Nephrol VL - 63 UR - https://doi.org/10.5414/CNP63250 DO - 10.5414/CNP63250 ID - Sharma2005 ER - TY - JOUR AU - Lacourciere, Y. AU - Tytus, R. AU - O'Keefe, D. AU - Lenis, J. AU - Orchard, R. AU - Martin, K. PY - 2001 DA - 2001// TI - Efficacy and tolerability of a fixed-dose combination of telmisartan plus hydrochlorothiazide in patients uncontrolled with telmisartan monotherapy JO - J Hum Hypertens VL - 15 UR - https://doi.org/10.1038/sj.jhh.1001267 DO - 10.1038/sj.jhh.1001267 ID - Lacourciere2001 ER - TY - JOUR AU - McGill, J. B. AU - Reilly, P. A. PY - 2001 DA - 2001// TI - Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, double-blind, placebo-controlled, parallel-group trial JO - Clin Ther VL - 23 UR - https://doi.org/10.1016/S0149-2918(01)80072-2 DO - 10.1016/S0149-2918(01)80072-2 ID - McGill2001 ER - TY - JOUR AU - Neutel, J. M. AU - Littlejohn, T. W. AU - Chrysant, S. G. AU - Singh, A. PY - 2005 DA - 2005// TI - Telmisartan/Hydrochlorothiazide in comparison with losartan/hydrochlorothiazide in managing patients with mild-to-moderate hypertension JO - Hypertens Res VL - 28 UR - https://doi.org/10.1291/hypres.28.555 DO - 10.1291/hypres.28.555 ID - Neutel2005 ER - TY - JOUR AU - Sharma, A. M. AU - Davidson, J. AU - Koval, S. AU - Lacourciere, Y. PY - 2007 DA - 2007// TI - Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study JO - Cardiovasc Diabetol VL - 6 UR - https://doi.org/10.1186/1475-2840-6-28 DO - 10.1186/1475-2840-6-28 ID - Sharma2007 ER - TY - JOUR AU - White, W. B. AU - Davidai, G. AU - Schumacher, H. PY - 2009 DA - 2009// TI - Impact of angiotensin receptor blockade in combination with hydrochlorothiazide 25 mg in 2121 patients with stage 1-2 hypertension JO - J Hum Hypertens VL - 23 UR - https://doi.org/10.1038/jhh.2009.28 DO - 10.1038/jhh.2009.28 ID - White2009 ER - TY - JOUR AU - Littlejohn, T. W. AU - Majul, C. R. AU - Olvera, R. AU - Seeber, M. AU - Kobe, M. AU - Guthrie, R. AU - Oigman, W. PY - 2009 DA - 2009// TI - Results of treatment with telmisartan-amlodipine in hypertensive patients JO - J Clin Hypertens (Greenwich ) VL - 11 UR - https://doi.org/10.1111/j.1751-7176.2009.00098.x DO - 10.1111/j.1751-7176.2009.00098.x ID - Littlejohn2009 ER - TY - JOUR AU - Sharma, A. AU - Bagchi, A. AU - Kinagi, S. B. AU - Sharma, Y. K. AU - Baliga, V. P. AU - Bollmall, C. PY - 2007 DA - 2007// TI - Results of a comparative, phase III, 12-week, multicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed-dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stage II hypertension JO - Clin Ther VL - 29 UR - https://doi.org/10.1016/j.clinthera.2007.12.017 DO - 10.1016/j.clinthera.2007.12.017 ID - Sharma2007 ER - TY - JOUR AU - Lacourciere, Y. AU - Gil-Extremera, B. AU - Mueller, O. AU - Byrne, M. AU - Williams, L. PY - 2003 DA - 2003// TI - Efficacy and tolerability of fixed-dose combinations of telmisartan plus HCTZ compared with losartan plus HCTZ in patients with essential hypertension JO - Int J Clin Pract VL - 57 ID - Lacourciere2003 ER - TY - JOUR AU - Lacourciere, Y. AU - Neutel, J. M. AU - Schumacher, H. PY - 2005 DA - 2005// TI - Comparison of fixed-dose combinations of telmisartan/hydrochlorothiazide 40/12.5 mg and 80/12.5 mg and a fixed-dose combination of losartan/hydrochlorothiazide 50/12.5 mg in mild to moderate essential hypertension: pooled analysis of two multicenter, prospective, randomized, open-label, blinded-end point (PROBE) trials JO - Clin Ther VL - 27 UR - https://doi.org/10.1016/j.clinthera.2005.11.014 DO - 10.1016/j.clinthera.2005.11.014 ID - Lacourciere2005 ER - TY - JOUR AU - Barnett, A. H. AU - Bain, S. C. AU - Bouter, P. AU - Karlberg, B. AU - Madsbad, S. AU - Jervell, J. AU - Mustonen, J. PY - 2004 DA - 2004// TI - Angiotensin-receptor blockade versus converting-enzyme inhibition in type 2 diabetes and nephropathy JO - N Engl J Med VL - 351 UR - https://doi.org/10.1056/NEJMoa042274 DO - 10.1056/NEJMoa042274 ID - Barnett2004 ER - TY - JOUR AU - Abe, M. AU - Okada, K. AU - Maruyama, T. AU - Matsumoto, S. AU - Matsumoto, K. PY - 2010 DA - 2010// TI - Blood pressure-lowering and antiproteinuric effect of switching from high-dose angiotensin receptor blockers to normal-dose telmisartan and low-dose hydrochlorothiazide in hypertensive patients with chronic kidney disease JO - Int J Clin Pharmacol Ther VL - 48 UR - https://doi.org/10.5414/CPP48206 DO - 10.5414/CPP48206 ID - Abe2010 ER - TY - JOUR AU - Schumacher, H. AU - Mancia, G. PY - 2008 DA - 2008// TI - The safety profile of telmisartan as monotherapy or combined with hydrochlorothiazide: a retrospective analysis of 50 studies JO - Blood Press Suppl VL - 1 UR - https://doi.org/10.1080/08038020802144383 DO - 10.1080/08038020802144383 ID - Schumacher2008 ER - TY - JOUR AU - Abe, M. AU - Okada, K. AU - Matsumoto, K. PY - 2009 DA - 2009// TI - Clinical experience in treating hypertension with fixed-dose combination therapy: angiotensin II receptor blocker losartan plus hydrochlorothiazide JO - Expet Opin Drug Metabol Toxicol VL - 5 UR - https://doi.org/10.1517/17425250903282799 DO - 10.1517/17425250903282799 ID - Abe2009 ER - TY - JOUR AU - Black, H. R. AU - Bailey, J. AU - Zappe, D. AU - Samuel, R. PY - 2009 DA - 2009// TI - Valsartan: more than a decade of experience JO - Drugs VL - 69 UR - https://doi.org/10.2165/11319460-000000000-00000 DO - 10.2165/11319460-000000000-00000 ID - Black2009 ER - TY - JOUR AU - Neutel, J. M. AU - Franklin, S. S. AU - Bhaumik, A. AU - Lapuerta, P. AU - Oparil, S. PY - 2009 DA - 2009// TI - Safety and tolerability of fixed-dose irbesartan/hydrochlorothiazide for rapid control of severe hypertension JO - Clin Exp Hypertens VL - 31 UR - https://doi.org/10.3109/10641960902929420 DO - 10.3109/10641960902929420 ID - Neutel2009 ER - TY - JOUR AU - White, W. B. AU - Littlejohn, T. W. AU - Majul, C. R. AU - Oigman, W. AU - Olvera, R. AU - Seeber, M. AU - Schumacher, H. AU - Mancia, G. PY - 2010 DA - 2010// TI - Effects of telmisartan and amlodipine in combination on ambulatory blood pressure in stages 1-2 hypertension JO - Blood Press Monit VL - 15 UR - https://doi.org/10.1097/MBP.0b013e32833c5722 DO - 10.1097/MBP.0b013e32833c5722 ID - White2010 ER - TY - JOUR AU - Guthrie, R. M. AU - Dahlof, B. AU - Jamerson, K. A. AU - Olvera, R. AU - Seeber, M. AU - Schumacher, H. AU - Oigman, W. PY - 2011 DA - 2011// TI - Efficacy and tolerability of telmisartan plus amlodipine in added-risk hypertensive patients JO - Curr Med Res Opin VL - 27 UR - https://doi.org/10.1185/03007995.2011.616490 DO - 10.1185/03007995.2011.616490 ID - Guthrie2011 ER - TY - CHAP AU - Sharma, A. M. AU - Bakris, G. AU - Neutel, J. M. AU - Littlejohn, T. W. AU - Kobe, M. AU - Ting, N. AU - Ley, L. PY - 2011 DA - 2011// TI - Single-Pill Combination of Telmisartan/Amlodipine vs Amlodipine Monotherapy in Diabetic Hypertensive Patients: an 8-week randomised, parallel group, double blind trial BT - Clin Ther ID - Sharma2011 ER - TY - JOUR PY - 2004 DA - 2004// TI - K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease JO - Am J Kidney Dis VL - 43 ID - ref108 ER - TY - JOUR AU - Matsui, Y. AU - Eguchi, K. AU - Ishikawa, J. AU - Shimada, K. AU - Kario, K. PY - 2011 DA - 2011// TI - Urinary albumin excretion during angiotensin II receptor blockade: comparison of combination treatment with a diuretic or a calcium-channel blocker JO - Am J Hypertens VL - 24 UR - https://doi.org/10.1038/ajh.2010.240 DO - 10.1038/ajh.2010.240 ID - Matsui2011 ER - TY - JOUR AU - Bakris, G. L. AU - Sarafidis, P. A. AU - Weir, M. R. AU - Dahlof, B. AU - Pitt, B. AU - Jamerson, K. AU - Velazquez, E. J. AU - Staikos-Byrne, L. AU - Kelly, R. Y. AU - Shi, V. AU - Chiang, Y. T. AU - Weber, M. A. PY - 2010 DA - 2010// TI - Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial JO - Lancet VL - 375 UR - https://doi.org/10.1016/S0140-6736(09)62100-0 DO - 10.1016/S0140-6736(09)62100-0 ID - Bakris2010 ER - TY - JOUR AU - Jamerson, K. AU - Weber, M. A. AU - Bakris, G. L. AU - Dahlof, B. AU - Pitt, B. AU - Shi, V. AU - Hester, A. AU - Gupte, J. AU - Gatlin, M. AU - Velazquez, E. J. PY - 2008 DA - 2008// TI - Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients JO - N Engl J Med VL - 359 UR - https://doi.org/10.1056/NEJMoa0806182 DO - 10.1056/NEJMoa0806182 ID - Jamerson2008 ER - TY - JOUR AU - Jamerson, K. A. AU - Bakris, G. L. AU - Weber, M. A. PY - 2010 DA - 2010// TI - 24-hour ambulatory blood pressure in the ACCOMPLISH trial JO - N Engl J Med VL - 363 UR - https://doi.org/10.1056/NEJMc1001410 DO - 10.1056/NEJMc1001410 ID - Jamerson2010 ER - TY - JOUR AU - Jamerson, K. A. AU - Devereux, R. AU - Bakris, G. L. AU - Dahlof, B. AU - Pitt, B. AU - Velazquez, E. J. AU - Weir, M. AU - Kelly, R. Y. AU - Hua, T. A. AU - Hester, A. AU - Weber, M. A. PY - 2011 DA - 2011// TI - Efficacy and duration of benazepril plus amlodipine or hydrochlorothiazide on 24-hour ambulatory systolic blood pressure control JO - Hypertension VL - 57 UR - https://doi.org/10.1161/HYPERTENSIONAHA.110.159939 DO - 10.1161/HYPERTENSIONAHA.110.159939 ID - Jamerson2011 ER - TY - JOUR AU - Cooper-DeHoff, R. M. AU - Pacanowski, M. A. AU - Pepine, C. J. PY - 2009 DA - 2009// TI - Cardiovascular therapies and associated glucose homeostasis: implications across the dysglycemia continuum JO - J Am Coll Cardiol VL - 53 UR - https://doi.org/10.1016/j.jacc.2008.10.037 DO - 10.1016/j.jacc.2008.10.037 ID - Cooper-DeHoff2009 ER - TY - JOUR AU - Elliott, W. J. AU - Meyer, P. M. PY - 2007 DA - 2007// TI - Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis JO - Lancet VL - 369 UR - https://doi.org/10.1016/S0140-6736(07)60108-1 DO - 10.1016/S0140-6736(07)60108-1 ID - Elliott2007 ER - TY - JOUR AU - Martinez-Martin, F. J. AU - Rodriguez-Rosas, H. AU - Peiro-Martinez, I. AU - Soriano-Perera, P. AU - Pedrianes-Martin, P. AU - Comi-Diaz, C. PY - 2011 DA - 2011// TI - Olmesartan/amlodipine vs olmesartan/hydrochlorothiazide in hypertensive patients with metabolic syndrome: the OLAS study JO - J Hum Hypertens VL - 25 UR - https://doi.org/10.1038/jhh.2010.104 DO - 10.1038/jhh.2010.104 ID - Martinez-Martin2011 ER - TY - JOUR AU - Touyz, R. M. PY - 2005 DA - 2005// TI - Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II JO - Exp Physiol VL - 90 UR - https://doi.org/10.1113/expphysiol.2005.030080 DO - 10.1113/expphysiol.2005.030080 ID - Touyz2005 ER - TY - JOUR AU - Parving, H. H. AU - Lehnert, H. AU - Brochner-Mortensen, J. AU - Gomis, R. AU - Andersen, S. AU - Arner, P. PY - 2001 DA - 2001// TI - The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes JO - N Engl J Med VL - 345 UR - https://doi.org/10.1056/NEJMoa011489 DO - 10.1056/NEJMoa011489 ID - Parving2001 ER - TY - JOUR AU - Lewis, E. J. AU - Hunsicker, L. G. AU - Clarke, W. R. AU - Berl, T. AU - Pohl, M. A. AU - Lewis, J. B. AU - Ritz, E. AU - Atkins, R. C. AU - Rohde, R. AU - Raz, I. PY - 2001 DA - 2001// TI - Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes JO - N Engl J Med VL - 345 UR - https://doi.org/10.1056/NEJMoa011303 DO - 10.1056/NEJMoa011303 ID - Lewis2001 ER - TY - JOUR AU - Brenner, B. M. AU - Cooper, M. E. AU - de, Z. D. AU - Keane, W. F. AU - Mitch, W. E. AU - Parving, H. H. AU - Remuzzi, G. AU - Snapinn, S. M. AU - Zhang, Z. AU - Shahinfar, S. PY - 2001 DA - 2001// TI - Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy JO - N Engl J Med VL - 345 UR - https://doi.org/10.1056/NEJMoa011161 DO - 10.1056/NEJMoa011161 ID - Brenner2001 ER - TY - JOUR AU - Viberti, G. AU - Wheeldon, N. M. PY - 2002 DA - 2002// TI - Microalbuminuria reduction with valsartan in patients with type 2 diabetes mellitus: a blood pressure-independent effect JO - Circulation VL - 106 UR - https://doi.org/10.1161/01.CIR.0000024416.33113.0A DO - 10.1161/01.CIR.0000024416.33113.0A ID - Viberti2002 ER - TY - JOUR AU - Bakris, G. AU - Burgess, E. AU - Weir, M. AU - Davidai, G. AU - Koval, S. PY - 2008 DA - 2008// TI - Telmisartan is more effective than losartan in reducing proteinuria in patients with diabetic nephropathy JO - Kidney Int VL - 74 UR - https://doi.org/10.1038/ki.2008.204 DO - 10.1038/ki.2008.204 ID - Bakris2008 ER - TY - JOUR AU - Haller, H. AU - Ito, S. AU - Izzo, J. L. AU - Januszewicz, A. AU - Katayama, S. AU - Menne, J. AU - Mimran, A. AU - Rabelink, T. J. AU - Ritz, E. AU - Ruilope, L. M. AU - Rump, L. C. AU - Viberti, G. PY - 2011 DA - 2011// TI - Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes JO - N Engl J Med VL - 364 UR - https://doi.org/10.1056/NEJMoa1007994 DO - 10.1056/NEJMoa1007994 ID - Haller2011 ER - TY - JOUR AU - Galle, J. AU - Schwedhelm, E. AU - Pinnetti, S. AU - Boger, R. H. AU - Wanner, C. PY - 2008 DA - 2008// TI - Antiproteinuric effects of angiotensin receptor blockers: telmisartan versus valsartan in hypertensive patients with type 2 diabetes mellitus and overt nephropathy JO - Nephrol Dial Transplant VL - 23 UR - https://doi.org/10.1093/ndt/gfn230 DO - 10.1093/ndt/gfn230 ID - Galle2008 ER - TY - JOUR AU - Yusuf, S. AU - Sleight, P. AU - Pogue, J. AU - Bosch, J. AU - Davies, R. AU - Dagenais, G. PY - 2000 DA - 2000// TI - Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators JO - N Engl J Med VL - 342 UR - https://doi.org/10.1056/NEJM200001203420301 DO - 10.1056/NEJM200001203420301 ID - Yusuf2000 ER - TY - JOUR AU - Mann, J. F. AU - Schmieder, R. E. AU - Dyal, L. AU - cQueen, M. AU - Schumacher, H. AU - Pogue, J. AU - Wang, X. AU - robstfield, J. L. AU - Avezum, A. AU - Cardona-Munoz, E. AU - Dagenais, G. R. AU - Diaz, R. AU - Fodor, G. AU - Maillon, J. M. AU - Rydén, L. AU - Yu, C. M. AU - Teo, K. K. AU - Yusuf, S. PY - 2009 DA - 2009// TI - Effect of telmisartan on renal outcomes: a randomized trial JO - Ann Intern Med VL - 151 UR - https://doi.org/10.7326/0003-4819-151-1-200907070-00122 DO - 10.7326/0003-4819-151-1-200907070-00122 ID - Mann2009 ER - TY - JOUR AU - Mann, J. F. AU - Schmieder, R. E. AU - McQueen, M. AU - Dyal, L. AU - Schumacher, H. AU - Pogue, J. AU - Wang, X. AU - Maggioni, A. AU - Budaj, A. AU - Chaithiraphan, S. AU - Dickstein, K. AU - Keltai, M. AU - Metsarinne, K. AU - Oto, A. AU - Parkhomenko, A. AU - Piegas, L. S. AU - Svendsen, T. L. AU - Teo, K. K. AU - Yusuf, S. PY - 2008 DA - 2008// TI - Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial JO - Lancet VL - 372 UR - https://doi.org/10.1016/S0140-6736(08)61236-2 DO - 10.1016/S0140-6736(08)61236-2 ID - Mann2008 ER - TY - JOUR AU - Ritz, E. AU - Schmieder, R. E. AU - Pollock, C. A. PY - 2010 DA - 2010// TI - Renal protection in diabetes: lessons from ONTARGET JO - Cardiovasc Diabetol VL - 9 UR - https://doi.org/10.1186/1475-2840-9-60 DO - 10.1186/1475-2840-9-60 ID - Ritz2010 ER - TY - JOUR AU - Malacco, E. AU - Santonastaso, M. AU - Vari, N. A. AU - Gargiulo, A. AU - Spagnuolo, V. AU - Bertocchi, F. AU - Palatini, P. PY - 2004 DA - 2004// TI - Comparison of valsartan 160 mg with lisinopril 20 mg, given as monotherapy or in combination with a diuretic, for the treatment of hypertension: the Blood Pressure Reduction and Tolerability of Valsartan in Comparison with Lisinopril (PREVAIL) study JO - Clin Ther VL - 26 UR - https://doi.org/10.1016/S0149-2918(04)90129-4 DO - 10.1016/S0149-2918(04)90129-4 ID - Malacco2004 ER -